Trxade Group Stock Fundamentals
| MEDSDelisted Stock | USD 7.46 0.56 8.12% |
Trxade Group fundamentals help investors to digest information that contributes to Trxade's financial success or failures. It also enables traders to predict the movement of Trxade Stock. The fundamental analysis module provides a way to measure Trxade's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Trxade stock.
Trxade |
Trxade Group Company Return On Asset Analysis
Trxade's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Trxade Return On Asset | -0.72 |
Most of Trxade's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Trxade Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Trxade Group has a Return On Asset of -0.7192. This is 91.78% lower than that of the Consumer Staples Distribution & Retail sector and significantly lower than that of the Consumer Staples industry. The return on asset for all United States stocks is notably higher than that of the company.
Trxade Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Trxade's current stock value. Our valuation model uses many indicators to compare Trxade value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Trxade competition to find correlations between indicators driving Trxade's intrinsic value. More Info.Trxade Group is considered to be number one stock in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Trxade by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Trxade Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trxade's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Trxade could also be used in its relative valuation, which is a method of valuing Trxade by comparing valuation metrics of similar companies.Trxade is currently under evaluation in return on asset category among its peers.
Trxade Fundamentals
| Return On Equity | -2.69 | |||
| Return On Asset | -0.72 | |||
| Profit Margin | 0.57 % | |||
| Operating Margin | (79.99) % | |||
| Current Valuation | 5.69 M | |||
| Shares Outstanding | 1.75 M | |||
| Shares Owned By Insiders | 61.69 % | |||
| Shares Owned By Institutions | 6.92 % | |||
| Number Of Shares Shorted | 15 K | |||
| Price To Book | 1.12 X | |||
| Price To Sales | 1.78 X | |||
| Revenue | 8.27 M | |||
| Gross Profit | 4.58 M | |||
| EBITDA | (6.19 M) | |||
| Net Income | (13.72 M) | |||
| Cash And Equivalents | 962.23 K | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 7.1 M | |||
| Debt To Equity | 0.93 % | |||
| Current Ratio | 1.32 X | |||
| Book Value Per Share | 8.38 X | |||
| Cash Flow From Operations | (2.07 M) | |||
| Short Ratio | 0.28 X | |||
| Earnings Per Share | (24.38) X | |||
| Target Price | 6.75 | |||
| Number Of Employees | 10 | |||
| Beta | 2.17 | |||
| Market Capitalization | 13.28 M | |||
| Total Asset | 12.53 M | |||
| Retained Earnings | (33.25 M) | |||
| Working Capital | (8.8 M) | |||
| Current Asset | 1.12 M | |||
| Current Liabilities | 49 K | |||
| Annual Yield | 0.27 % | |||
| Net Asset | 12.53 M |
About Trxade Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Trxade Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trxade using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trxade Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. Trxade Health operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Trxade Stock
If you are still planning to invest in Trxade Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Trxade's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |